- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Apr 30, 2025 | 59.75M sh |
| Cash And Equivalents | Q3 2025 · Mar 28, 2025 | $269.82M |
| Cash And Equivalents | Q3 2025 · Jun 28, 2024 | $180.52M |
| Current Liabilities | Q3 2025 · Mar 28, 2025 | $296.56M |
| Current Liabilities | Q3 2025 · Jun 28, 2024 | $234.42M |
| Total Liabilities | Q3 2025 · Mar 28, 2025 | $963.33M |
| Total Liabilities | Q3 2025 · Jun 28, 2024 | $906.13M |
| Current Assets | Q3 2025 · Mar 28, 2025 | $1.02B |
| Current Assets | Q3 2025 · Jun 28, 2024 | $953.78M |
| Total Assets | Q3 2025 · Mar 28, 2025 | $2.41B |
| Total Assets | Q3 2025 · Jun 28, 2024 | $2.38B |
| Shares Diluted | Q3 2025 · Mar 29, 2024 | 57.7M sh |
| Shares Diluted | Q3 2025 · Mar 29, 2024 | 57.54M sh |
| Stock Repurchased | Q3 2025 · Mar 29, 2024 | $15K |
| Capex | Q3 2025 · Mar 29, 2024 | $23.94M |
| Operating Cash Flow | Q3 2025 · Mar 29, 2024 | −$11.38M |
| Stockholders Equity | Q3 2025 · Mar 29, 2024 | $1.47B |
| Stockholders Equity | Q3 2025 · Dec 29, 2023 | $1.5B |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $1.57B |
| Eps Diluted | Q3 2025 · Mar 29, 2024 | −$0.77 |
| Eps Diluted | Q3 2025 · Mar 29, 2024 | −$2.20 |
| Eps Basic | Q3 2025 · Mar 29, 2024 | −$0.77 |
| Eps Basic | Q3 2025 · Mar 29, 2024 | −$2.20 |
| Sga Expense | Q3 2025 · Mar 29, 2024 | $43.16M |
| Sga Expense | Q3 2025 · Mar 29, 2024 | $123.42M |
| Rd Expense | Q3 2025 · Mar 29, 2024 | $21.56M |
| Rd Expense | Q3 2025 · Mar 29, 2024 | $81.91M |
| Net Income | Q3 2025 · Mar 29, 2024 | −$44.57M |
| Net Income | Q3 2025 · Mar 29, 2024 | −$126.86M |
| Operating Income | Q3 2025 · Mar 29, 2024 | −$45.66M |
| Operating Income | Q3 2025 · Mar 29, 2024 | −$139.79M |
| Gross Profit | Q3 2025 · Mar 29, 2024 | $40.64M |
| Gross Profit | Q3 2025 · Mar 29, 2024 | $122.69M |
| Cost Of Revenue | Q3 2025 · Mar 29, 2024 | $167.62M |
| Cost Of Revenue | Q3 2025 · Mar 29, 2024 | $464.02M |
| Revenue | Q3 2025 · Mar 29, 2024 | $208.26M |
| Revenue | Q3 2025 · Mar 29, 2024 | $586.71M |